{"id":"W2128083415","doi":"10.1016/s1470-2045(13)70510-2","title":"Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial","year":2013,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":526,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Juravinski Cancer Centre; Institut universitaire de cardiologie et de pneumologie de Québec; Alberta Cancer Foundation","funders":"Merck KGaA","keywords":"Medicine; Placebo; Chemoradiotherapy; Clinical endpoint; Internal medicine; Population; Lung cancer; Surgery; Phases of clinical research; Hazard ratio; Cancer; Clinical trial; Oncology; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001521571,0.002229594,0.003744986,0.0005758571,0.0005005682,0.001238661,0.00110215,0.002458773,0.009692902],"category_scores_gemma":[0.0012174,0.0008728124,0.002502776,0.0005107832,0.001584506,0.001486668,0.0005187819,0.003705723,0.002101091],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007027338,"about_ca_system_score_gemma":0.001000623,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001154491,"about_ca_topic_score_gemma":0.002590209,"domain_scores_codex":[0.9994963,0.0002319308,0.00002777818,0.00009432945,0.0000375193,0.0001121479],"domain_scores_gemma":[0.999411,0.0001719724,0.0001137219,0.00004900932,0.000029643,0.000224565],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9881495,0.002179265,0.000109468,0.0004953792,0.0004148042,0.00002211364,0.00002894622,0.0001592926,0.001296781,0.00007125848,0.0005770327,0.006496032],"study_design_scores_gemma":[0.9738649,0.02507753,0.000298236,0.00002208384,0.0001621302,0.00001049691,0.00001122289,0.0001112776,0.0001421251,0.00006165403,0.0002299055,0.00000848329],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9718168,0.01031269,0.001435527,0.000928454,0.001417689,0.007302948,0.002374579,0.0004737588,0.003937555],"genre_scores_gemma":[0.9736639,0.004668603,0.001935993,0.00141856,0.0006481945,0.008136789,0.001596551,0.00005747624,0.007873814],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009692902,"threshold_uncertainty_score":0.032426,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08993665752350942,"score_gpt":0.4353921749557403,"score_spread":0.3454555174322309,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}